Instructions and treatments


Health Canada has authorized the use of PaxlovidTM in Canada. This is the first oral treatment specifically for COVID-19. It comes in tablet form.

PaxlovidTM is intended to reduce the severity of COVID-19 symptoms in people at risk of developing serious complications from this infection. It is estimated to reduce the risk of hospitalization or death from COVID-19.

PaxlovidTM treatment must be started within five days of the appearance of COVID-19 symptoms. It must be taken at the home of the person who has COVID-19 for five consecutive days.

Lets continue to protect ouselves